Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - TOTAL CURRENT LIABILITIES
Total Current Liabilities KROS - Keros Therapeutics, Inc.
24.4 M
LAST VALUE
43.44%
2 YEAR CAGR
16.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR